Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Summary
This trial is designed to assess the tolerability, safety, pharmacokinetic profile, and preliminary efficacy of the combination of ZGGS18 and ZG005 in patients with advanced solid tumors, including advanced cervical cancer, hepatocellular carcinoma, neuroendocrine cancer, and lung cancer.
Official title: A Phase I/II Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors, Including Cervical Cancer, Hepatocellular Carcinoma, Neuroendocrine Tumors, and Lung Cancer
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-05-20
Completion Date
2028-04
Last Updated
2026-01-05
Healthy Volunteers
No
Conditions
Interventions
ZGGS18 for Injection
Intravenous infusion
ZG005 for Injection
Intravenous infusion
Locations (1)
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China